A Leading Health Diagnostics Company
Dedicated to Improving the Lives of Women and Babies
Through Individualized Prenatal Care
The Pregnancy Company
Preterm birth impacts over 1 in 10 U.S. pregnancies.1
Accurately identifying women at higher risk for spontaneous preterm birth is a critical first step to addressing an early delivery’s health and economic impacts. The PreTRM® Test predicts a patient’s individual risk of spontaneous preterm delivery in asymptomatic singleton pregnancies through a single blood draw performed during weeks 19 or 20 gestational age.
News and Press Releases
September 28, 2021- Brings extensive data science, bioinformatics and proteomics experience to foster further product innovation and informed healthcare insights into pregnancy
September 15, 2021- Dr. Foley will lead all medical activities for Sera as the company executes its vision to be the Pregnancy Company.
September 14, 2021- Publication illustrates clinical benefit of combining PreTRM® testing with evidence-based interventions to improve neonatal health and reduce total health costs.
Make a Difference in the Health of Moms and Babies
By working together, we can innovate with bold ideas to give babies the best start in life. Our team is passionate about becoming the global leader in high-value women’s health diagnostics. We are dedicated to improving the lives of women and babies through precision pregnancy care.
- Hamilton BE, et al. Births: Provisional data for 2020. Vital Statistics Rapid Release; no 12. Hyattsville, MD: National Center for Health Statistics. May 2021.